Modulation of peroxisome proliferator–activated receptor γ stability and transcriptional activity in adipocytes by resveratrol

Lagouge, 2006, Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1[alpha], Cell, 127, 1109, 10.1016/j.cell.2006.11.013 Baur, 2006, Resveratrol improves health and survival of mice on a high-calorie diet, Nature, 444, 280, 10.1038/nature05354 Picard, 2004, Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma, Nature, 429, 771, 10.1038/nature02583 Howitz, 2003, Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan, Nature, 425, 191, 10.1038/nature01960 Kliewer, 1997, Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator–activated receptors alpha and gamma, Proc Natl Acad Sci U S A, 94, 4318, 10.1073/pnas.94.9.4318 Medina-Gomez, 2005, The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator–activated receptor–gamma2 isoform, Diabetes, 54, 1706, 10.2337/diabetes.54.6.1706 Kubota, 1999, PPAR gamma mediates high-fat diet–induced adipocyte hypertrophy and insulin resistance, Mol Cell, 4, 597, 10.1016/S1097-2765(00)80210-5 Miles, 2003, Effect of heterozygous PPARgamma deficiency and TZD treatment on insulin resistance associated with age and high-fat feeding, Am J Physiol Endocrinol Metab, 284, E618, 10.1152/ajpendo.00312.2002 Miles, 2000, Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency, J Clin Invest, 105, 287, 10.1172/JCI8538 Rieusset, 2004, Altered growth in male peroxisome proliferator–activated receptor gamma (PPARgamma) heterozygous mice: involvement of PPARgamma in a negative feedback regulation of growth hormone action, Mol Endocrinol, 18, 2363, 10.1210/me.2003-0325 Stewart, 2004, STAT 5 activators can replace the requirement of FBS in the adipogenesis of 3T3-L1 cells, Biochem Biophys Res Commun, 324, 355, 10.1016/j.bbrc.2004.09.053 Floyd, 2002, Interferon-gamma–mediated activation and ubiquitin-proteasome–dependent degradation of PPARgamma in adipocytes, J Biol Chem, 277, 4062, 10.1074/jbc.M108473200 Laemmli, 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature, 227, 680, 10.1038/227680a0 Waite, 2001, Interferon-gamma–induced regulation of peroxisome proliferator–activated receptor gamma and STATs in adipocytes, J Biol Chem, 276, 7062, 10.1074/jbc.M007894200 Gomez-Lechon, 1996, A microassay for measuring glycogen in 96-well cultured cells, Anal Biochem, 236, 296, 10.1006/abio.1996.0170 Hauser, 2000, Degradation of the peroxisome proliferator–activated receptor gamma is linked to ligand-dependent activation, J Biol Chem, 275, 18527, 10.1074/jbc.M001297200 Ge, 2007, Resveratrol inhibits macrophage expression of EMMPRIN by activating PPARgamma, Vasc Pharmacol, 46, 114, 10.1016/j.vph.2006.08.412 Inoue, 2003, Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator–activated receptor alpha in mice, Neurosci Lett, 352, 203, 10.1016/j.neulet.2003.09.001 Ulrich, 2006, Peroxisome proliferator–activated receptor gamma as a molecular target of resveratrol-induced modulation of polyamine metabolism, Cancer Res, 66, 7348, 10.1158/0008-5472.CAN-05-2777 Yan, 2006, Pim-1 kinase inhibits the activation of reporter gene expression in Elk-1 and c-Fos reporting systems but not the endogenous gene expression: an artifact of the reporter gene assay by transient co-transfection, Braz J Med Biol Res, 39, 169, 10.1590/S0100-879X2006000200002 Chattopadhyay, 1998, A nuclear matrix attachment region upstream of the T cell receptor beta gene enhancer binds Cux/CDP and SATB1 and modulates enhancer-dependent reporter gene expression but not endogenous gene expression, J Biol Chem, 273, 29838, 10.1074/jbc.273.45.29838 Schoonjans, 1996, The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation, Biochim Biophys Acta, 1302, 93, 10.1016/0005-2760(96)00066-5 Hua, 1991, Cloning and characterization of the promoter of the murine lipoprotein lipase–encoding gene: structural and functional analysis, Gene, 107, 247, 10.1016/0378-1119(91)90325-6 Tontonoz, 1994, mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer, Genes Dev, 8, 1224, 10.1101/gad.8.10.1224 Devine, 1999, Adipose expression of the phosphoenolpyruvate carboxykinase promoter requires peroxisome proliferator–activated receptor gamma and 9-cis-retinoic acid receptor binding to an adipocyte-specific enhancer in vivo, J Biol Chem, 274, 13604, 10.1074/jbc.274.19.13604 Tontonoz, 1995, PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene, Mol Cell Biol, 15, 351, 10.1128/MCB.15.1.351 Tordjman, 2003, Thiazolidinediones block fatty acid release by inducing glyceroneogenesis in fat cells, J Biol Chem, 278, 18785, 10.1074/jbc.M206999200 Brady, 1998, The activation of glycogen synthase by insulin switches from kinase inhibition to phosphatase activation during adipogenesis in 3T3-L1 cells, J Biol Chem, 273, 14063, 10.1074/jbc.273.23.14063 Jensen, 2000, Specific desensitization of glycogen synthase activation by insulin in 3T3-L1 adipocytes. Connection between enzymatic activation and subcellular localization, J Biol Chem, 275, 40148, 10.1074/jbc.M004902200 Lehmann, 1995, An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator–activated receptor gamma (PPARgamma), J Biol Chem, 270, 12953, 10.1074/jbc.270.22.12953 Gray, 2006, Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator–activated receptor gamma function (P465L PPARgamma) in mice, Diabetes, 55, 2669, 10.2337/db06-0389 Larsen, 2003, PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy?, Int J Obes Relat Metab Disord, 27, 147, 10.1038/sj.ijo.802223 Floyd, 2004, Control of peroxisome proliferator–activated receptor gamma2 stability and activity by SUMOylation, Obes Res, 12, 921, 10.1038/oby.2004.112 Koubova, 2003, How does calorie restriction work?, Genes Dev, 17, 313, 10.1101/gad.1052903 Bluher, 2003, Extended longevity in mice lacking the insulin receptor in adipose tissue, Science, 299, 572, 10.1126/science.1078223 Barzilai, 2001, The role of fat depletion in the biological benefits of caloric restriction, J Nutr, 131, 903S, 10.1093/jn/131.3.903S Liao, 2007, Suppression of PPARγ attenuates insulin-stimulated glucose uptake by affecting both GLUT1 and GLUT4 in 3T3-L1 adipocytes, Am J Physiol Endocrinol Metab, 293, E219, 10.1152/ajpendo.00695.2006